[Treatment of intestinal infections. Infectious diarrhea is frequent also in developed countries].

B. Svenungsson

1994-09-07

Abstract:

What problem does this paper attempt to address?

Infectious diarrhoea

Paul Kelly,Phoebe Hodges

DOI: https://doi.org/10.1016/j.mpmed.2024.01.008

IF: 1.6

2024-02-01

Medicine

Abstract:Infectious diarrhoea remains a major cause of morbidity and mortality worldwide. Viruses, bacteria and protozoa are responsible for most infections, which are most commonly transmitted by the faecal–oral route through water, food and person-to-person transmission. The clinical presentation conforms to four patterns: acute watery diarrhoea; bloody diarrhoea (dysentery); persistent non-bloody diarrhoea, which can include steatorrhoea; and persistent bloody diarrhoea. Diagnosis still rests heavily on stool microscopy and culture, although faecal antigen tests and molecular assays are increasingly used. Oral rehydration therapy continues to be the most important supportive intervention, particularly in acute watery diarrhoea, in which death from dehydration and acidosis can be prevented in the vast majority of cases. There have been some important advances in the development of new approaches to antibiotic therapy. The non-absorbable antibiotic rifaximin is highly effective in the treatment of travellers' diarrhoea and has fewer adverse effects than systemically absorbed antibiotics. The broad-spectrum antimicrobial nitazoxanide is often effective in treating cryptosporidiosis but is also effective in giardiasis, amoebiasis and Clostridioides (Clostridium) difficile infection. Recent meta-analyses suggest that promicrobial therapies, including faecal microbial transplantation, have a place in the prophylaxis and treatment of antibiotic-associated diarrhoea, especially Clostridioides difficile infection, and acute diarrhoea in children.

medicine, general & internal
Intestinal infections due to various protozoan and helminth parasites and bacteria in a tertiary care institute

Sheetal Goenka,Monika Matlani,Vinita Dogra,,,

DOI: https://doi.org/10.52768/2766-7820/1683

2022-02-22

Journal of Clinical Images and Medical Case Reports

Abstract:Diarrhoea due to intestinal parasites and bacteria are prevalent in individuals belonging to the lower socio-economic strata. Infectious intestinal diseases are often self-limiting. They are usually treated without proper diagnosis or information about the etiology. Important bacteria causing diarrhoea are diarrhoeagenic Escherichia coli, Shigella spp, Salmonella spp, and Vibrio cholerae. The common enteric parasites like Giardia lamblia, Entamoeba histolytica, Ascaris lumbricoides, Ancylostoma duodenale, Trichuris trichiura, Enterobius vermicularis, Hymenolepis nana and Strongyloides stercoralis are responsible for considerable morbidity and mortality in the extremes of age. As these parasitic infections are often overlooked, the identification of these pathogenic organisms is of great importance for proper treatment and institution of control measures.Improving the quality of the water, sanitation, and overall hygiene can help prevent diarrhoeal diseases. The accurate diagnosis of the causative agents, an institution of proper treatment and regular monitoring of antimicrobial resistance profiles will help in preventing the spread of multidrug-resistant strains in the community.

English Else
Progress on treatment of acute infectious diarrhea in adults

SUN Feng,ZHANG Wen-Hong

2013-01-01

Abstract:Acute infectious diarrhea in adults is different from children infectious diarrhea in incidence rate, severity and prognosis.Fluid infusion and antidiarrheal treatment are suggested first and antibiotics are prescribed under the needed conditions.Current medical evidences in fluid infusion,probiotics and new antidiarrheal medicines for acute infectious diarrhea in adults are summarized in this paper.Accumulated evidences demonstrate that these treatments are safe and effective.
Combatting infectious diarrhea: innovations in treatment and vaccination strategies

Vivek P. Chavda,Suneetha Vuppu,Toshika Mishra,Sathvika Kamaraj,Nikita Sharma,Swati Punetha,Anand Sairam,Dixa Vaghela,Narges Dargahi,Vasso Apostolopoulos,Vivek P. ChavdaSuneetha VuppuToshika MishraSathvika KamarajNikita SharmaSwati PunethaAnand SairamDixa VaghelaNarges DargahiVasso Apostolopoulosa Department of Pharmaceutics and Pharmaceutical Technology,LM College of Pharmacy,Ahmedabad,Gujarat,Indiab Department of Biotechnology,Science,Innovation,and Society Research Lab 115,Hexagon (SMV),Vellore Institute of Technology,Vellore,Tamil Nadu,Indiac Pharmacy Section,L.M. College of Pharmacy,Ahmedabad,Gujarat,Indiad Institute for Health and Sport,Victoria University,Melbourne,Australiae Australian Institute for Musculoskeletal Science (AIMSS),Immunology Program,Sunshine Hospital Campus,Saint Albans,Victoria,Australia

DOI: https://doi.org/10.1080/14760584.2023.2295015

2024-02-20

Expert Review of Vaccines

Abstract:Introduction The escalating prevalence of infectious diseases is an important cause of concern in society. Particularly in several developing countries, infectious diarrhea poses a major problem, with a high fatality rate, especially among young children. The condition is divided into four classes, namely, acute diarrhea, invasive diarrhea, acute bloody diarrhea, and chronic diarrhea. Various pathogenic agents, such as bacteria, viruses, protozoans, and helminths, contribute to the onset of this condition.

immunology
Gastrointestinal Conditions: Acute Infectious Gastroenteritis and Colitis

Justin M Bailey

Abstract:Gastroenteritis is inflammation of the stomach and intestines; colitis is inflammation of the colon. Viruses are the most common cause, followed by bacteria and parasites. Incidence of the various infections varies by age, sex, location, and vaccine availability; vaccination has reduced rotavirus infections by as much as 90% in children. Postinfectious complications include irritable bowel syndrome (IBS) and lactose intolerance. Approximately 9% of patients with acute gastroenteritis or colitis develop postinfectious IBS, which accounts for more than 50% of all IBS cases. The diagnostic approach to gastroenteritis and colitis varies with symptom severity. Microbial studies are not needed with mild symptoms that resolve within a week, but longer-lasting or more severe symptoms (including bloody stool) warrant microbial studies. In addition, recent antibiotic exposure should prompt testing for Clostridioides difficile. Multiplex antimicrobial testing is preferred; stool cultures and microscopic stool examinations are no longer first-line tests. Management depends on severity. Patients with mild or moderate symptoms are treated with oral hydration if tolerated; nasogastric or intravenous hydration are used for those with more severe illness. In addition, antiemetic, antimotility, and/or antisecretory drugs can be used for symptom control. Antimicrobial therapy is indicated for C difficile infections, travel-related diarrhea, other bacterial infections with severe symptoms, and parasitic infections.
Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets.

Taheri Sathaliyawala,Masaru Kubota,N. Yudanin,D. Turner,Philip Camp,J. Thome,K. Bickham,H. Lerner,Michael Goldstein,M. Sykes,Tomoaki Kato,D. Farber

DOI: https://doi.org/10.1016/j.immuni.2012.09.020

IF: 32.4

2013-01-24

Immunity

Abstract:
The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies

Selma P. Wiertsema,Jeroen van Bergenhenegouwen,Johan Garssen,Leon M. J. Knippels

DOI: https://doi.org/10.3390/nu13030886

IF: 5.9

2021-03-09

Nutrients

Abstract:Infectious diseases and infections remain a leading cause of death in low-income countries and a major risk to vulnerable groups, such as infants and the elderly. The immune system plays a crucial role in the susceptibility, persistence, and clearance of these infections. With 70–80% of immune cells being present in the gut, there is an intricate interplay between the intestinal microbiota, the intestinal epithelial layer, and the local mucosal immune system. In addition to the local mucosal immune responses in the gut, it is increasingly recognized that the gut microbiome also affects systemic immunity. Clinicians are more and more using the increased knowledge about these complex interactions between the immune system, the gut microbiome, and human pathogens. The now well-recognized impact of nutrition on the composition of the gut microbiota and the immune system elucidates the role nutrition can play in improving health. This review describes the mechanisms involved in maintaining the intricate balance between the microbiota, gut health, the local immune response, and systemic immunity, linking this to infectious diseases throughout life, and highlights the impact of nutrition in infectious disease prevention and treatment.

nutrition & dietetics
Epidemiology, Etiology and Pathophysiology of Traveler’s Diarrhea

Joaquim Gascón

DOI: https://doi.org/10.1159/000089785

2006-01-01

Digestion

Abstract:Traveler's diarrhea (TD) is the most frequent health problem in travelers to developing countries. Several personal and environmental risk factors are at the basis of TD acquisition and are discussed in this paper. TD is caused by a wide range of infectious organisms, ETEC and EAEC bacteria strains being the main enteropathogens incriminated in TD. Other causative bacteria are: Shigella spp., Campylobacter spp., Vibrio spp., Aeromonas spp., Salmonella spp., and Plesiomonas spp. Parasite species are also included: Cyclospora cayetanensis, Giardia lamblia, Cryptosporidium, Entamoeba histolytica, as well as viruses: rotavirus, adenovirus, Norwalk virus. Due to the great diversity of pathogens incriminated, several pathophysiological mechanisms have been described and some of them are still poorly understood. The clinical symptoms present are also quite variable, although inflammatory and non-inflammatory diarrhea have been established as a classical and basic classification of diarrhea.
The 12 Gastrointestinal Pathogens Spectrum of Acute Infectious Diarrhea in a Sentinel Hospital, Shenzhen, China

Hongwei Shen,Jinjin Zhang,Yinghui Li,Sirou Xie,Yixiang Jiang,Yanjie Wu,Yuhui Ye,Hong Yang,Haolian Mo,Chaoman Situ,Qinghua Hu

DOI: https://doi.org/10.3389/fmicb.2016.01926

IF: 5.2

2016-01-01

Frontiers in Microbiology

Abstract:Acute infectious gastroenteritis is one of the most common diseases among all ages, particularly in developing countries. The pathogen spectrum may differ among different regions and seasons. To investigate the etiology of acute diarrhea in Shenzhen, a prospective study was conducted from August 2014 to September 2015. Stools from 412 patients with diarrhea (286 of whom were adults) including the general epidemiological information of the patients were collected. The 19 pathogens were detected by conventional culture method or multiplex PCR assay, which included five viruses (rotavirus, adenovirus, sapovirus, norovirus, and astrovirus), 11 bacterial pathogens (Salmonella, Campylobacter jejuni, Shigella, Listeria monocytogenes, Vibrio parahaemolyticus, Vibrio cholera, Enterohemorrhagic (EHEC), enteropathogenic (EPEC), enteroinvasive (EIEC), enterotoxigenic (ETEC); and enteroaggregative Escherichia coli (EAEC)) and three parasites (Entamoeba histolytica, Giardia lamblia, and Cryptosporidium parvum). A potential pathogen and coinfection was found in 41.5 and 7.0% of cases, respectively. The bacterial infection was the dominant cause of diarrhea (32.3%), and the three most frequently identified organisms were Salmonella (12.1%), ETEC (8.0%), and Campylobacter jejuni (4.9%). Salmonella enteritidis was the leading serotype of Salmonella sp. Norovirus (8.3%) and sapovirus (2.2%) were the most common viral pathogens, followed by adenovirus (1.5%) and rotavirus (1.2%). No EHEC, L. monocytogenes, V. cholera, Shigella, and parasites were found. The single most important causes of diarrhea were Salmonella spp. and Campylobacter jejuni, which points toward the need for testing and surveillance for these pathogens in this region.
[Vaccination against diarrheal diseases and typhoid fever. Current status and prospects]

B Ivanoff,M Neira

Abstract:Diarrheal diseases and typhoid fever are still common in developing countries and there is still a search for effective control measures able to prevent the epidemics they cause from time to time. There are recommended preventive measures based on health education and improvement of sewage and water facilities; however these recommendations given for many years have not reached the expected results for different reasons. Antibiotherapy was very effective for many years; unfortunately increasing antibiotic resistance has been reported, particularly in Shigella and typhoid fever treatment. This explains the re-kindled interest currently taking place in vaccines development against infections due to V. cholerae, Shigella, E.coli ETEC, S. typhi and rotavirus. The new available vaccines are very effective and provide greater protection than that given by the old killed injectable vaccines. They paved the way for development of new candidate vaccines easier to deliver (oral vaccines or one dose parenteral vaccine), which already give promising results. Some of these candidate vaccines like those related to Shigella infections are considered as a future promising tool for controlling diarrhea due to Shigella.
Infections Diarrhea Bacterial Pathogens Monitoring and Resistance to Antibiotics in Beijing

侯凤琴,王勇,孙新婷,王贵强

DOI: https://doi.org/10.3969/j.issn.1001-6821.2008.04.004

2008-01-01

Abstract:Objective To investigate the distribution, the resistance of bacterial pathogens isolated from acute diarrheal patients in Beijing. Methods Enteric pathogenic bacteria were isolated by feces culture. Antimicrobial susceptibility were carried out in Kirby-bauer method.Results Shigella spp.(23.4%) was still the most frequently detected pathogen in all of the pathogens resulted in diarrhea. The rate of conditional pathogenic bacteria such as Bacterium termo, Enterococci, and so on increased to 32.4%. The rate of resistence of bacterial pathogens often caused diarrhea to both ampicllin and trimethoprim-sulfamethoxazole were within 40%～100%, while to fluoroquinolones were less than 15%(excepted for Saimonella 20%), and to the third generation of cephalosporins were about 10%.Conclusion The rate of conditional pathogenic bacteria increased,which should be taken seriously . The rates of resistence of all pathogens caused diarrhea to fluoroquinolones were less than 20%, so can be remained as first-line medicines for infectious diarrhea.
Diarrhoea of unknown cause: medical treatment in a stepwise manner

Ann-Sofie Jansson-Rehnberg,Asbjørn Mohr Drewes,Jon Sponheim,Christer Borgfelt,Andreas Münch,Wilhelm Graf,Magnus Simrén,Greger Lindberg,Per M. Hellström

DOI: https://doi.org/10.1080/00365521.2024.2313061

2024-02-13

Scandinavian Journal of Gastroenterology

Abstract:The basic principle for the treatment of idiopathic diarrhoea (functional diarrhoea K59.1) is to delay transit through the gut in order to promote the absorption of electrolytes and water. Under mild conditions, bulking agents may suffice. With increasing severity, antidiarrhoeal pharmaceuticals may be added in a stepwise manner. In diarrhoea of unknown aetiology, peripherally-acting opioid receptor agonists, such as loperamide, are first-line treatment and forms the pharmaceutical basis of antidiarrheal treatment. As second-line treatment opium drops have an approved indication for severe diarrhoea when other treatment options fail. Beyond this, various treatment options are built on experience with more advanced treatments using clonidine, octreotide, as well as GLP-1 and GLP-2 analogs which require specialist knowledge the field. Chronic diarrhoea without an established cause is common. There are a small number of clinical trials, often with a limited number of patients or healthy volunteers. Treatment is often carried out on a trial-and-error basis, with considerable variation in the choice of treatment. There is a paucity of guidelines, and there is a gap in knowledge concerning treatment goals, such as the frequency, consistency and form of stool. The stepwise approach to the treatment of chronic idiopathic diarrhoea described in this article is based on clinical knowledge and experience.

gastroenterology & hepatology
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens

Sohn Kim,April Covington,Eric G. Pamer

DOI: https://doi.org/10.1111/imr.12563

2017-08-30

Immunological Reviews

Abstract:The human gastrointestinal tract hosts a diverse network of microorganisms, collectively known as the microbiota that plays an important role in health and disease. For instance, the intestinal microbiota can prevent invading microbes from colonizing the gastrointestinal tract, a phenomenon known as colonization resistance. Perturbations to the microbiota, such as antibiotic administration, can alter microbial composition and result in the loss of colonization resistance. Consequently, the host may be rendered susceptible to colonization by a pathogen. This is a particularly relevant concern in the hospital setting, where antibiotic use and antibiotic-resistant pathogen exposure are more frequent. Many nosocomial infections arise from gastrointestinal colonization. Due to their resistance to antibiotics, treatment is often very challenging. However, recent studies have demonstrated that manipulating the commensal microbiota can prevent and treat various infections in the intestine. In this review, we discuss the members of the microbiota, as well as the mechanisms, that govern colonization resistance against specific pathogens. We also review the effects of antibiotics on the microbiota, as well as the unique epidemiology of immunocompromised patients that renders them a particularly high-risk population to intestinal nosocomial infections.

immunology
Gastrointestinal infections in children

Michael Gracey

DOI: https://doi.org/10.1097/00001574-199202000-00018

1992-02-01

Current Opinion in Gastroenterology

Abstract:&NA; This review discusses reports on childhood diarrhea published in the past year. Interesting and important epidemiologic studies are covered, some with implications for vaccine development; and there are sections on some of the major enteric microorganisms. There is also discussion on risk factors for childhood diarrhea, which are important in developing preventive strategies. The review ends with some recent developments in diagnostic techniques, a commentary on some original papers, and some useful reviews about treatment of childhood diarrheal disease. Current Opinion in Gastroenterology 1992, 8:115-121

gastroenterology & hepatology
Probiotics, prebiotics, and synbiotics in childhood diarrhea

E.M.S. Martins,L.C. Nascimento da Silva,M.S. Carmo

DOI: https://doi.org/10.1590/1414-431x2024e13205

2024-04-21

Brazilian Journal of Medical and Biological Research

Abstract:Martins, E.m.s. ; Nascimento Da Silva, L.c. ; Carmo, M.s. ; Acute diarrhea is the second leading cause of morbidity and mortality attributed to infections in children under five years of age worldwide, with 1.7 million annual estimated cases and more than 500,000 deaths. Although hydroelectrolytic replacement is the gold standard in treating diarrhea, it does not interfere with the restoration of the intestinal microbiota. Several studies have searched for an adequate alternative in restructuring intestinal homeostasis, finding that treatments based on probiotics, prebiotics, and synbiotics are effective, which made such treatments increasingly present in clinical practice by reducing illness duration with minimal side effects. However, there are still controversies regarding some unwanted reactions in patients. The diversity of strains and the peculiarities of the pathogens that cause diarrhea require further studies to develop effective protocols for prevention and treatment. Here, we provide a descriptive review of childhood diarrhea, emphasizing treatment with probiotics, prebiotics, and synbiotics.

medicine, research & experimental,biology
Clostridioides difficile Infections: Prevention and Treatment Strategies

Elvira Ingrid Levy,Meltem Dinleyici,Ener Dinleyici,Yvan Vandenplas

DOI: https://doi.org/10.1007/978-3-031-58572-2_11

Abstract:Clostridioides difficile is the most common causative agent of antibiotic-associated diarrhea. This spore forming, obligate anaerobic, gram-positive bacillus is becoming responsible for an increasing number of infections worldwide, both in community and in hospital settings, whose severity can vary widely from an asymptomatic infection to a lethal disease. While discontinuation of antimicrobial agents and antibiotic treatment of the infection remain the cornerstone of therapy, more recent fecal microbiota transplantation has also been valid as a therapy. The use of probiotics, especially Saccharomyces boulardii CNCM I-745 have become valid forms of prevention therapy. Although there are studies in adults with microbiota-targeted new generation therapies and Clostridium difficile vaccines, there are no data in the paediatric age group yet.
Status Quo of Treatment for Antibiotic-associated Diarrhea

Howard R. Champion,Nova L. Panebianco,Jan J. De Waele,Lewis J. Kaplan,Manu L. N. G. Malbrain,Annie L. Slaughter,Walter L. Biffl,Clay Cothren Burlew,Ernest E. Moore,Parita Bhuva,Barnett R. Nathan,Michael E. Silverman,Richard D. Shih,Luciano Gattinoni,E. Carlesso,Pietro Caironi,Argyris Michalopoulos,Matthew E. Falagas,Angela M. Mills,Anthony J. Dean,Christopher R. Wyatt,Ernest E. Moore,Clay Cothren Burlew,Chadwick D. Miller,Karina M. Soto-Ruiz,Joseph Varon,W. Frank Peacock,Prasad Devarajan,Arun Jeyabalan,Joan R. Badia,José A. Lorente,Nicolás Nin,Ramsey J. Daher,Mark D. Okusa,Rui P. Moreno,Djillali Annane,Brenna M. Farmer,Claudio Ronco,Zaccaria Ricci,Jameel Ali,Richard D. Branson,Bryce R. H. Robinson,Lara Wijayasiri,Andrew Rhodes,Maurizio Cecconi,Stuart F. Reynolds,Peter G. Brindley,John A. Kellum,Nattachai Srisawat,Patrick D. Brophy,Michelle Baack,John A. Kellum,Nattachai Srisawat,Eric A. J. Hoste,Edward T. Dickinson,Alexander L. Colonna,J. Wayne Meredith,Ali El-Solh,Brian H. Rowe,Howard L. Corwin,Joel M. Bartfield,Thomas M. Scalea,Kareem R. AbdelFattah,Joseph P. Minei,Patrick T. Murray,Caitlin W. Hicks,Peter Q. Eichacker,S. Uddin,Susanna Price,Joseph P. Lynch,Anne-Cornélie J. M. Pont,Tyler W. Barrett,Brett F. Bechtel,David F. Gaieski,Munish Goyal,Mette M. Berger,Lucas Liaudet,Pascal Vranckx,Marco Valgimigli,P. W. Serruys,Ian Loftus,Charles S. Brudney,Srini Pyati,Charles S. Brudney,Juan B. Ochoa,Mary K. Miranowski,Rebecca M. Dodson,Sandra L. Kavalukas,Adrian Barbul,Jonathan R. Egan,Marino S. Festa,Samir H. Haddad,Yaseen M. Arabi,David W. Collins,Yahya Shehabi,Steven E. Carsons,Wouter Meersseman,Daniel K. Resnick,Basheal M. Agrawal,Griet Thielen,Susanna Price

DOI: https://doi.org/10.3969/j.issn.1672-2124.2007.06.002

2007-01-01

Abstract:OBJECTIVE:To evaluate the cause,mechanism,risk factors and status of the diagnosis and treatment of antibiotic-associated diarrhea(AAD).METHODS: We analyzed the pertinent literature both at home and abroad.RESULTS & CONCLUSION: AAD is most often caused by the use of antibiotics,in that the normal flora in intestinal tract was destructed,gastrointestinal motility was accelerated and intestinal mucous membrane was damaged.Once diagnosed as having this disease, patients should have a withdrawal of antibiotics.Most of the mild cases can have a spontaneous cure after drug withdrawal,but for severe cases,antibiotic treatment should be conducted aimed at clostridium difficiles.Rational use of antibiotics is the key to prevent AAD.
Intestinal Parasitic Infections in 2023

Monjur Ahmed

DOI: https://doi.org/10.14740/gr1622

2023-06-12

Gastroenterology Research

Abstract:Intestinal parasites include intestinal protozoa and intestinal helminths. Intestinal parasitic infections (IPIs) pose a global health problem affecting over one billion people worldwide. Although these infections are predominantly seen in the developing world, they are frequently seen in the developed countries, particularly in immunocompromised patients. Patients' clinical presentations generally include diarrhea, dysentery, abdominal pain, nausea, vomiting, nutritional deficiency, iron deficiency anemia, anal and perianal itching, and rarely intestinal obstruction. The intestinal parasites have similarities in their mode of transmission and life cycle. The stool test is the primary way of diagnosing IPIs. Treatment is given with various anti-parasitic agents. However, appropriate preventive measures are essential for successfully controlling the IPIs. Gastroenterol Res. 2023;16(3):127-140 doi: https://doi.org/10.14740/gr1622
[The lake frog (Rana ridibunda)--one of the food hosts of blood-sucking mosquitoes in Tadzhikistan--a reservoir of the West Nile fever virus].

M. A. Kostiukov,Z. E. Gordeeva,V. P. Bulychev,N. V. Nemova,O. Daniiarov

Abstract:
Medications for the prevention and treatment of travellers' diarrhea

David N Taylor,Davidson H Hamer,David R Shlim

DOI: https://doi.org/10.1093/jtm/taw097

2017-04-01

Abstract:Background: . Travellers' diarrhea (TD) remains one of the most common illnesses encountered by travellers to less developed areas of the world. Because bacterial pathogens such as enterotoxigenic Escherichia coli (ETEC), enteroaggregative E. coli , Campylobacter spp. and Shigella spp. are the most frequent causes, antibiotics have been useful in both prevention and treatment of TD. Methods.: Results of trials that assessed the use of medications for the prevention and treatment of TD were identified through PubMed and MEDLINE searches using search terms 'travellers' diarrhea', 'prevention' and 'treatment'. References of articles were also screened for additional relevant studies. Results.: Prevention of TD with antibiotics has been recommended only under special circumstances. Doxycycline, trimethoprim-sulfamethoxazole, fluoroquinolones and rifaximin have been used for prevention, but at present the first three antibiotics may have limited use secondary to increasing resistance, leaving rifaximin as the only current option. Bismuth subsalicylate (BSS) (Pepto-Bismol tablets) is also an option for prophylaxis. Treatment with antibiotics has been recommended for moderate to severe TD. Azithromycin is the drug of choice, especially in Asia where Campylobacter is common. Fluoroquinolone antibiotics continue to be effectively used in Latin America and Africa where ETEC is predominant. BSS and loperamide (LOP) also are effective as standalone treatments. LOP may be used alone for treatment of mild TD or in conjunction with antibiotics for treatment of TD. Conclusions: . Historically, antibiotic prophylaxis has not been routinely recommended and has been reserved for special circumstances such as when a traveller with an underlying illness cannot tolerate TD. Antibiotics with or without LOP have been useful in shortening the duration and severity of TD. Emerging antibiotic resistance, limited new antibiotic alternatives and faecal carriage of antibiotic-resistant bacteria by travellers may prompt a re-evaluation of classic recommendations for treatment and prevention of TD with antibiotics.

[Treatment of intestinal infections. Infectious diarrhea is frequent also in developed countries].

Infectious diarrhoea

Intestinal infections due to various protozoan and helminth parasites and bacteria in a tertiary care institute

Progress on treatment of acute infectious diarrhea in adults

Combatting infectious diarrhea: innovations in treatment and vaccination strategies

Gastrointestinal Conditions: Acute Infectious Gastroenteritis and Colitis

Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets.

The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies

Epidemiology, Etiology and Pathophysiology of Traveler’s Diarrhea

The 12 Gastrointestinal Pathogens Spectrum of Acute Infectious Diarrhea in a Sentinel Hospital, Shenzhen, China

[Vaccination against diarrheal diseases and typhoid fever. Current status and prospects]

Infections Diarrhea Bacterial Pathogens Monitoring and Resistance to Antibiotics in Beijing

Diarrhoea of unknown cause: medical treatment in a stepwise manner

The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens

Gastrointestinal infections in children

Probiotics, prebiotics, and synbiotics in childhood diarrhea

Clostridioides difficile Infections: Prevention and Treatment Strategies

Status Quo of Treatment for Antibiotic-associated Diarrhea

Intestinal Parasitic Infections in 2023

[The lake frog (Rana ridibunda)--one of the food hosts of blood-sucking mosquitoes in Tadzhikistan--a reservoir of the West Nile fever virus].

Medications for the prevention and treatment of travellers' diarrhea